REFERENCES

1. Gardasil®9 Prescribing Information for GB. Summary of Product Characteristics. Accessed March 2025. Available at: https://www.emcpi.com/pi/32240

 2. World Health Organization. Questions and answers about HPV vaccination: Information for parents and caregivers. Accessed March 2025. Available at: https://www.who.int/europe/publications/i/item/WHO-EURO-2020-5631-45396-64962

3. European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. An update. Published September 2012. Accessed March 2025. Available at: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/20120905_GUI_HPV_vaccine_update.pdf

4. UK Health Security Agency. Human Papillomavirus (HPV): The Green Book, Chapter 18a. March 2022. Available at: Human papillomavirus (HPV): the green book, chapter 18a GOV.UK (www.gov.uk) Last accessed: April 2025

5. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021 - human papillomavirus (HPV) infection. Accessed March 2025. Available at: https://www.cdc.gov/std/treatment-guidelines/hpv.htm

6. Muñoz N et al. J Infect Dis. 2004;190:2077–2087

7. Ingles DJ et al. Papillomavirus Res. 2015;1:126–135

8. European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. Published January 2008. Accessed March 2025. Available at: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0801_GUI_Introduction_of_HPV_Vaccines_in_EU.pdf

9. de Martel C et al. Lancet Glob Health. 2020;8:e180–e190

10. Falcaro M, et. Al. Lancet. 2021; 389:2084-2092​

11. World Health Organisation. Cervical cancer overview. Accessed March 2025. Available at: https://www.who.int/health-topics/cervical-cancer#tab=tab_1

 12. National Cancer Institute. HPV and Cancer. National Cancer Institute. Published January 31, 2025. Accessed April 22, 2025. https://prevention/risk/infectious-agents/hpv-and-cancer

ADDITIONAL RESOURCES

Gardasil®9 Prescribing Information for GB. Summary of Product Characteristics. Accessed Nov 2024. Available at: https://www.emcpi.com/pi/32240

European Centre for Disease Prevention and Control. EU vaccine scheduler. Accessed Nov 2024. Available at: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=38&SelectedCountryIdByDisease=-1

PROTECT EUROPE. Vaccinating Europe to protect against HPV cancers. Accessed Nov 2024. Available at: https://hpvhub.ipvsoc.org/protect-europe

This content has been developed and funded by Merck Sharp and Dohme (MSD).

GB-GSL-00825